J. Joist

发表

Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia.

G. Schonfeld, J. Joist, R. Baker, 1979, Thrombosis research.

Indium‐III: a New Radionuclide Label for Studying Human Platelet Kinetics

M. Welch, B. Siegel, L. Sherman, 1979, British journal of haematology.

Massive retroperitoneal pseudotumour in a patient with type 3 von Willebrand disease

C. Eby, S. Badar, J. Joist, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen?

J. Ladenson, J. M. Michael, G. Kessler, 1974, American journal of clinical pathology.

Experience with the pierce-Donachy ventricular assist device in postcardiotomy patients with cardiogenic shock

George A. Williams, D. Pennington, G. Williams, 1985, World Journal of Surgery.

A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.

P. Mannucci, Y. Laurian, C. Kasper, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.

E. Spitznagel, S. Santoro, L. Goodnough, 1994, The Journal of thoracic and cardiovascular surgery.

Aspirin sensitivity of platelet aggregation in diabetes mellitus.

A. Mooradian, S. Albert, J. Joist, 2005, Diabetes research and clinical practice.

Point-of-care assessment of haemostasis after cardiopulmonary bypass

L. Goodnough, J. Joist, G. Despotis, 1999, The Lancet.

In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.

S. Santoro, L. Goodnough, G. Despotis, 1994, Anesthesia and analgesia.

Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.

C. Hogue, S. Santoro, G. Despotis, 1995, Critical care medicine.

More Effective Suppression of Hemostatic System Activation in Patients Undergoing Cardiac Surgery by Heparin Dosing Based on Heparin Blood Concentrations rather than ACT

E. Spitznagel, C. Hogue, S. Santoro, 1996, Thrombosis and Haemostasis.

Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial

E. Spitznagel, G. Despotis, J. Joist, 1999, The Lancet.

Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms.

J. Joist, Salvatore, R. Reimers, 1984, Blood.

The Relationship Between Hirudin and Activated Clotting Time: Implications for Patients with Heparin-Induced Thrombocytopenia Undergoing Cardiac Surgery

C. Hogue, A. Qayum, G. Despotis, 2001, Anesthesia and analgesia.

Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.

S. Klahr, J. Joist, M. Purkerson, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Infections and thromboembolism with implantable cardiovascular devices.

B. Griffith, D. Pennington, F. Schoen, 1989, ASAIO transactions.

SCINTIGRAPHIC DETECTION OF ATHEROSCLEROTIC LESIONS AND VENOUS THROMBI IN MAN BY INDIUM-111-LABELLED AUTOLOGOUS PLATELETS

M. Welch, B. Siegel, C. Mathias, 1978, The Lancet.

Scintigraphic Detection of Carotid Atherosclerosis with Indium‐111‐labeled Autologous Platelets

M. Welch, B. Siegel, L. Sherman, 1980, Circulation.

An improved method for evaluation of blood coagulation in heparinized blood.

J. Vargo, J. Joist, J. F. Cowan, 1981, American journal of clinical pathology.

Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions.

M. Welch, R. Coleman, M. Thakur, 1976, Thrombosis research.

Effects of platelets and white blood cells and antiplatelet agent C7E3 (Reopro) on a new test of PAF procoagulant activity of whole blood.

S. Santoro, G. Despotis, J. Joist, 1997, Thrombosis research.

Role of platelet-prostaglandin synthesis in shear-induced platelet alterations.

J. Joist, S. Sutera, D. Stevens, 1980, Blood.

Hemofiltration During Cardiopulmonary Bypass: The Effect on Anti-Xa and Anti-IIa Heparin Activity

G. Despotis, K. Filos, J. Joist, 1997, Anesthesia and analgesia.

Indium-111-labeled human platelets: uptake and loss of label and in vitro function of labeled platelets.

M. Welch, M. Thakur, J. Joist, 1978, The Journal of laboratory and clinical medicine.

Retention of Platelet Fibrin Stabilizing Factor during the Platelet Release Reaction and Clot Retraction

J. Joist, S. Niewiarowski, 1973, Thrombosis and Haemostasis.

New Insights into How Blood Clots: Implications for the Use of APTT and PT as Coagulation Screening Tests and in Monitoring of Anticoagulant Therapy

S. Bajaj, J. Joist, PH.D S. PAUL BAJAJ, 1999, Seminars in thrombosis and hemostasis.

The direct visualization of blood flow by real-time ultrasound: clinical observations and underlying mechanisms.

M. Wolverson, M. Sundaram, J. Joist, 1981, Radiology.

HTLV-III/LAV antibody status of spouses and household contacts assisting in home infusion of hemophilia patients.

D. Lawrence, J. Jason, B. Evatt, 1985, Blood.

Antithrombin III During Cardiac Surgery: Effect on Response of Activated Clotting Time to Heparin and Relationship to Markers of Hemostatic Activation

G. Despotis, J. Joist, D. Joiner-Maier, 1997, Anesthesia and analgesia.

Impaired thromboxane synthesis in preactivated human blood platelets: agonist-specific, irreversible desensitization to thrombin.

J. Joist, H. Reimers, R. K. Baker, 1987, Thrombosis research.

Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.

D. Domoto, J. Bauman, J. Joist, 1991, Thrombosis research.

Demonstration and partial characterization of insulin receptors in human platelets.

W. Daughaday, L. Jarett, A. Hajek, 1979, The Journal of clinical investigation.

Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets.

J. Mustard, R. Kinlough-Rathbone, J. Joist, 1976, Thrombosis research.

Arachidonic acid-induced platelet aggregation independent of ADP-release in a patient with a bleeding disorder due to platelet storage pool disease.

P. Needleman, J. Joist, M. Minkes, 1979, Thrombosis research.

Platelet reactions with artificial surfaces.

D. Pennington, J. Joist, 1987, ASAIO transactions.

Factors influencing shear-induced platelet alterations: platelet lysis is independent of platelet aggregation and release.

J. Joist, M. Moritz, S. Sutera, 1981, Thrombosis research.

Venous thromboembolism and transient thrombocytopenia in a patient with diabetes insipidus treated with desmopressin acetate (DDAVP).

S. Albert, J. Joist, V. Salvato-Lechner, 1988, Thrombosis research.

Platelet function, blood coagulability, and fibrinolysis in patients with low tension glaucoma.

A. Kolker, J. Joist, P. Lichtenfeld, 1976, Archives of ophthalmology.

Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats.

S. Klahr, J. M. Greenberg, J. Joist, 1982, Thrombosis research.

Venous and arterial thrombosis : pathogenesis, diagnosis, prevention, and therapy

L. Sherman, J. Joist, 1979 .

Loss of 51chromium, lactate dehydrogenase, and 111indium as indicators of endothelial cell injury.

J. Joist, R. Webster, J. Chopra, 1987, Laboratory investigation; a journal of technical methods and pathology.

North American study of factor VIII concentrate potency.

F. Ofosu, J. Lusher, S. Chavin, 2009, Scandinavian journal of haematology. Supplementum.

Effect of aprotinin on activated clotting time, whole blood and plasma heparin measurements.

S. Santoro, L. Goodnough, G. Despotis, 1995, The Annals of thoracic surgery.

Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.

G. Despotis, J. Joist, 1999, Journal of cardiothoracic and vascular anesthesia.

Pharmacokinetic analysis of plasma‐derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B

C. Leissinger, A. Shapiro, B. Ewenstein, 2002, Transfusion.

The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.

E. Spitznagel, C. Hogue, S. Santoro, 1995, The Journal of thoracic and cardiovascular surgery.

Panel 3 Bleeding and anticoagulation

J. Copeland, L. Harker, J. Joist, 1989 .

Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes.

L. Goodnough, G. Despotis, J. Joist, 1997, Clinical chemistry.

Evaluation of a New Point-of-care Test that Measures PAF-mediated Acceleration of Coagulation in Cardiac Surgical Patients

S. Santoro, L. Goodnough, G. Despotis, 1996, Anesthesiology.

Aspirin-Dipyridamole Prophylaxis of Sickle Cell Disease Pain Crises

A. Fletcher, H. Chaplin, N. Alkjaersig, 1980, Thrombosis and Haemostasis.

Transjugular intrahepatic portosystemic shunt for palliation of bleeding esophageal varices in a patient with severe hemophilia A, advanced HIV infection, and cirrhosis.

B. Bacon, D. Zuckerman, J. Joist, 1993, The American journal of gastroenterology.

Experimental hemarthrosis in dogs: progressive synovitis monitored with technetium-99m pyrophosphate joint imaging.

J. Joist, L. Samuels, G. Restrepo, 1988, Haemostasis.

Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements.

E. Spitznagel, S. Santoro, L. Goodnough, 1997, The Journal of thoracic and cardiovascular surgery.

A multicenter clinical evaluation of the Clot Signature Analyzer

A. Schmaier, P. Kouides, K. Jagadeesan, 2004, Journal of thrombosis and haemostasis : JTH.

Shear-induced aggregation and lysis of platelets.

R M Hochmuth, R. Hochmuth, T C Hung, 1976, Transactions - American Society for Artificial Internal Organs.

DDAVP REDUCES BLOOD LOSS AND TRANSFUSION IN CARDIAC SURGICAL PATIENTS WITH IMPAIRED PLATELET FUNCTION IDENTIFIED USING A POINT-OF-CARE TEST: A DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

E. Spitznagel, G. Despotis, J. Joist, 1998 .

Platelet adhesion and aggregation in pulsatile shear flow: effects of red blood cells.

S. Sutera, J. Bauman, J. Joist, 1998, Thrombosis research.

A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery

G. Despotis, J. Joist, D. Joiner-Maier, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

AICF and DIC in Liver Cirrhosis: Expressions of a Hypercoagulable State

J. Joist, H. Joist, 1999, American Journal of Gastroenterology.

Case report 133

M. Wolverson, M. Sundaram, J. Joist, 1980 .

Case report 133. Hemophilic pseudotumor of ilium and soft tissues.

M. Wolverson, M. Sundaram, J. Joist, 1981, Skeletal radiology.

Gastrointestinal histoplasmosis presenting as hematochezia in human immunodeficiency virus‐infected hemophilic patients

P. Becherer, M. Sokol-Anderson, J. Joist, 1994, American journal of hematology.

Platelet factor 4--antiheparin protein releasable from platelets. Purification and properties.

J. Joist, S. Niewiarowski, N. Nath, 1973, The Journal of laboratory and clinical medicine.

Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms

J. Joist, R. C. Reimers, S. P. Sutera, 1984 .

Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress.

J. Joist, M. Moritz, R. Reimers, 1983, The Journal of laboratory and clinical medicine.

Activation of human platelets by N-substituted aminophospholipids.

T. W. Martin, J. Bauman, D. Lagunoff, 1985, The Journal of biological chemistry.

Fibrinopeptide A in the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.

J. Joist, 1984, Clinics in laboratory medicine.

Inhibition and potentiation of platelet function by lysolecithin.

J. Mustard, E. Nishizawa, M. Cucuianu, 1977, Blood.

The Effect of Barbituric Acid Derivatives on Platelet Function in Vitro and in Vivo

J. Cazenave, J. Mustard, J. Joist, 1973, Thrombosis and Haemostasis.

Isolation and characterization of pro coagulant substances from human ascites

J. Vargo, J. Joist, M. F. Johnston, 1981 .

Hypercoagulability: introduction and perspective.

J. Joist, 1990, Seminars in thrombosis and hemostasis.

Platelet antiplasmin: its extrusion during the release reaction, subcellular localization, characterization, and relationship to antiheparin in pig platelets.

J. Mustard, J. Joist, S. Niewiarowski, 1976, The Journal of laboratory and clinical medicine.

Heparin lysolecithin, and platelet function.

J. Mustard, J. Joist, 1975, Advances in experimental medicine and biology.

Methodologic and Basic Aspects of Indium-111 Platelets

M. Welch, J. Joist, Joist Jh, 1983, Seminars in thrombosis and hemostasis.

A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions.

S. Sutera, J. Bauman, J H Joist, 1988, Biorheology.

Disappearance of a high response factor VIII inhibitor in a hemophiliac with AIDS.

J. Joist, A. Knutsen, W. Leyva, 1988, American journal of clinical pathology.

Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.

D. Lawrence, J. Joist, J. Mcdougal, 1986, Annals of allergy.

Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.

J. Joist, T. Zimmerman, J. F. Cowan, 1978, The New England journal of medicine.

Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome.

T. Moore, T. Osborn, J. Joist, 1993, The Journal of rheumatology.

Comparison of plasmic hydrolysis of normal fibrinogen and fibrinogen Giessen I.

L. Sherman, M. Mosesson, J. Joist, 1978, Thrombosis research.

Loss of 111Indium as indicator of platelet injury.

J. Joist, R. K. Baker, 1981, Blood.

Phospholipid transfer between plasma and platelets in vitro.

J. Lloyd, J. Joist, G. Dolezel, 1974, Blood.

Platelet insulin receptor.

A. Hajek, J. Joist, 1992, Methods in enzymology.

Phospholipid transfer between plasma and platelets in vitro.

J. Mustard, J. Lloyd, J. Joist, 1976, Thrombosis research.

Further evaluation of a heparin neutralizer and its effect on factor IX in normal and coumadin-plasma.

J. Vargo, J. Joist, 1983, Thrombosis research.

Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.

J. Joist, J. F. Cowan, M. Khan, 1977, Journal of Laboratory and Clinical Medicine.

in home infusion of hemophilia patients HTLV-III/LAV antibody status of spouses and household contacts assisting

J. Joist, J. Mcdougal, A. Knutsen, 2011 .

Circulatory Support 1988. Bleeding and anticoagulation.

J. Copeland, L. Harker, J. Joist, 1989, Annals of Thoracic Surgery.

Effect of ADP‐Induced Aggregation on 32PO4 Incorporation into Phosphatidic Acid and the Phosphoinoistides of Rabbit Platelets

J. Mustard, J. Lloyd, E. Nishizawa, 1973, British journal of haematology.

[Studies on the nature and etiology of uremic thrombocytopathy].

J. Joist, R. Gross, G. Hübner, 1969, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin.

A randomized, double‐blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors

Shapiro, Kasper, Y. Laurian, 1998 .

Quantification of Wear, Hemolysis and Coagulation Deficits in Patients with Beall Mitral Valves

R. E. Clark, J. Joist, B. Knight, 1977, Circulation.